<--- Back to Details
First PageDocument Content
Carcinoma / Histopathology / Vismodegib / End point of clinical trials / Organic chemistry / Medicine / Oncology / Basal-cell carcinoma
Date: 2013-10-02 10:04:37
Carcinoma
Histopathology
Vismodegib
End point of clinical trials
Organic chemistry
Medicine
Oncology
Basal-cell carcinoma

NATIONAL CANCER DRUG FUND PRIORITISATION SCORES Drug Indication VISMODEGIB

Add to Reading List

Source URL: www.england.nhs.uk

Download Document from Source Website

File Size: 223,62 KB

Share Document on Facebook

Similar Documents

CMTF005 - Food is Medicine - Checklist_Debranded

CMTF005 - Food is Medicine - Checklist_Debranded

DocID: 1xVMk - View Document

Pacemakers and Implantable Cardiac Defibrillators: Software Radio Attacks and Zero-Power Defenses Daniel Halperin† Thomas S. Heydt-Benjamin†

Pacemakers and Implantable Cardiac Defibrillators: Software Radio Attacks and Zero-Power Defenses Daniel Halperin† Thomas S. Heydt-Benjamin†

DocID: 1xVge - View Document

CMTF005 - Food is Medicine - Checklist_Debranded_with bleed

CMTF005 - Food is Medicine - Checklist_Debranded_with bleed

DocID: 1xUza - View Document

CMTF005 - Food is Medicine - Checklist_Debranded_edited

CMTF005 - Food is Medicine - Checklist_Debranded_edited

DocID: 1xTtU - View Document

PDF Document

DocID: 1xSqy - View Document